drugset / Trial / NCT06229977
A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression
Phase 2
Completed
34 enrolled
The University of Texas Health Science Center, Houston
Baszucki Brain Research Fund · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to o evaluate the antidepressant efficacy of the PEA in Bipolar Depression and the association between antidepressant response with endogenous cannabinoids and cytokine levels
Timeline
- Start
- 2023-05-17
- Primary completion
- 2025-07-17
- Completion
- 2025-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palmidrol | Small molecule | 600 mg | — |